The Operating System for Biotech Execution
Berube BioVentures builds the coordination infrastructure connecting science, manufacturing, and capital—allowing biotechnology programs to move from discovery to industrial execution with clarity and speed.
126
Active Programs
$407M
Lifecycle Value (Low)
$1.09B
Lifecycle Value (Mid)
$1.5B+
Total Opportunity Value
The Next Phase of Biotechnology
Modern biotechnology is entering an infrastructure phase. Scientific discovery alone is no longer the bottleneck—coordination across development, manufacturing, and capital systems determines whether innovation scales.
Science
Manufacturable discovery and development architecture.
Manufacturing
Global CDMO network infrastructure aligned for execution.
Capital
Investor alignment and venture ecosystem development.
Infrastructure Platform
CDMO Network
Neutral routing infrastructure aligning biotech programs with manufacturing partners best positioned to execute.
Icarys Software
AI-augmented coordination software managing biotech development across sponsors and CDMOs.
Venture Ecosystem
Early-stage founders gain access to development strategy, manufacturing partners, and capital networks.
Pipeline Intelligence
Programs Detected
126 active biotechnology mandates across modalities.
Lifecycle Value
$1.5B+ potential program value across development stages.
Network Growth
Expanding CDMO and sponsor partnerships globally.
Engage the Ecosystem
Founders, CDMOs, investors, and partners are invited to participate in the next generation of biotech infrastructure.